Skip to content

A study for Efficacy and Safety of Metronomic Administration of Detoxification Chinese Herbs combined with Thalidomide in the Treatment of Elderly or Refractory Relapsed Lymphoma

A study for Efficacy and Safety of Metronomic Administration of Detoxification Chinese Herbs combined with Thalidomide in the Treatment of Elderly or Refractory Relapsed Lymphoma

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022510
Enrollment
Unknown
Registered
2019-04-14
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed or Refractory Non-Hodgkin's lymphoma

Interventions

Sponsors

Shanghai Municiple hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the pathological diagnostic criteria of lymphoma (pathological types are not limited); 2. Meet the diagnostic criteria for elderly or refractory or relapsed; 3. Patients assessed as inappropriate or intolerable or unwilling to receive combination chemotherapy and targeted therapy; 4. ECOG=3; 5. Survival is expected to be greater than 3 months; 6. Having signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Aged<18 years; 2. Pregnant or lactating women; 3. History of thrombosis nearly 2 years; 4. Allergic or allergic to various drugs; 5. Severe liver and kidney dysfunction; 6. With severe infection or difficult to control; 7. Taking other traditional Chinese medicine or taking other clinical trials nearly 2 weeks; 8. The investigators concluded that patients should not take any other part of the study.

Design outcomes

Primary

MeasureTime frame
Tumor volume;Quality of Life Assessment;VEGF;TCM symptom score;

Secondary

MeasureTime frame
LDH;ß2 microglobulin;

Countries

China

Contacts

Public ContactQi Hu

Shanghai Municiple hospital of Traditional Chinese Medicine

queenhu_cn@aliyun.com+86 13641951569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026